ArticleFrontiers in molecular biosciences2025
Using machine learning methods to investigate the role of volatile organic compounds in non-alcoholic fatty liver disease.
Article in Frontiers in molecular biosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Breath-Based Diagnostics in Liver Diseases: Dynamic Assessment of Hepatic Metabolic Reserve and Liver Fibrosis.Gastro hep advances · 2026Review
- Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review.Frontiers in oncology · 2026Review
- Harnessing serum VOCs and machine learning for the early detection of MAFLD.Frontiers in endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Approximately 25%-30% of the global population is affected by non-alcoholic fatty liver disease (NAFLD). This study aimed to explore whether NAFLD could be effectively detected using 341 volatile organic compounds (VOCs) via 10 machine learning (Mach-L) algorithms in a cohort of 1,501 individuals. Methods: Participants were selected from the Taiwan MJ cohort, which includes comprehensive demographic, biochemical, lifestyle, and VOCs data. NAFLD was diagnosed by experienced gastroenterologists. Exhaled breath samples were collected using a 1.0-L aluminum bag (late expiratory fraction) and analyzed with selected-ion flow-tube mass spectrometry. Ten Mach-L techniques were employed to evaluate two predictive models: Model 1 (demographic, lifestyle, and biochemical data), and Model 2 (Model 1 + VOCs), assessed using area under the receiver operating characteristic curve (AUC). Results: Subjects with NAFLD had significantly higher values for age, BMI, blood pressure, and other biomedical markers, except for eGFR and HDL-C. Key predictors of NAFLD included BMI, triglycerides (TG), uric acid (UA), fasting plasma glucose (FPG), γ-GT, gender, LDL-C, and sleep duration. The addition of VOCs to Model 1 improved the AUC from 0.722 ± 0.149 to 0.770 ± 0.264 (p < 0.001). Ten VOCs were identified as the most influential, in order of importance: 2-propanol, acetone, butyl 2-methylbutanoate, diethylethanolamine, urethane, β-caryophyllene, furfural, tridecane, 4-methyloctanoic acid, and (S)-2-methyl-1-butanol. Conclusion: Incorporating VOCs into traditional demographic, biochemical, and lifestyle data significantly enhanced the model's predictive performance. This suggests that VOCs may be associated with the underlying pathophysiology of NAFLD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.